Currently out of the existing stock ratings of William Tanner, 8 are a HOLD (27.59%), 20 are a BUY (68.97%), 1 are a SELL (3.45%).

William Tanner

Work Performance Price Targets & Ratings Chart

Analyst William Tanner, currently employed carries an average stock price target met ratio of 35.4% that have a potential upside of 19.45% achieved within 250 days.

William Tanner’s has documented 59 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on NVAX, Novavax at 15-Jun-2021.

Wall Street Analyst William Tanner

Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 7/7/2020. The price target of $148 was fulfilled within 21 days with a profit of $43.44 (41.55%) receiving and performance score of 19.78.

Average potential price target upside

NVAX Novavax AIMT Aimmune Therapeutics ALKS Alkermes Plc JAZZ Jazz Pharmaceuticals PLC PRTA Prothena plc TXMD TherapeuticsMD

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$19

$10.3 (118.39%)

$19

11 days ago
(10-Dec-2024)

15/24 (62.5%)

$10.1 (113.48%)

161

Buy

$26

$17.3 (198.85%)

$23

2 months 11 days ago
(10-Oct-2024)

16/41 (39.02%)

$13.09 (101.39%)

85

Sell

$9

$0.3 (3.45%)

$8

4 months 9 days ago
(12-Aug-2024)

7/9 (77.78%)

$-2.85 (-24.05%)

61

Hold

$18

$9.3 (106.90%)

$13

6 months 7 days ago
(14-Jun-2024)

3/4 (75%)

$3.6 (25.00%)

228

Hold

$10

$1.3 (14.94%)

$110

1 years 8 months 1 days ago
(20-Apr-2023)

1/6 (16.67%)

$1.77 (21.51%)

389

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by William Tanner?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?